Search alternatives:
shape decrease » shape increases (Expand Search), step decrease (Expand Search), showed decreased (Expand Search)
small decrease » small increased (Expand Search)
gap decrease » a decrease (Expand Search), gain decreased (Expand Search), mean decrease (Expand Search)
shape decrease » shape increases (Expand Search), step decrease (Expand Search), showed decreased (Expand Search)
small decrease » small increased (Expand Search)
gap decrease » a decrease (Expand Search), gain decreased (Expand Search), mean decrease (Expand Search)
-
1701
Network structure of OSA.
Published 2025“…For the purpose of further enhancing the processing capability of small-scale features, a small target detection head is first introduced to the detection layer of YOLOv8 in this paper with the aim of collecting more detailed information by increasing the detection resolution of YOLOv8 to ensure precise and fast detection. …”
-
1702
The performance of S-YOFEO model on MOT17.
Published 2025“…For the purpose of further enhancing the processing capability of small-scale features, a small target detection head is first introduced to the detection layer of YOLOv8 in this paper with the aim of collecting more detailed information by increasing the detection resolution of YOLOv8 to ensure precise and fast detection. …”
-
1703
Five multi-target tracking evaluation indexes.
Published 2025“…For the purpose of further enhancing the processing capability of small-scale features, a small target detection head is first introduced to the detection layer of YOLOv8 in this paper with the aim of collecting more detailed information by increasing the detection resolution of YOLOv8 to ensure precise and fast detection. …”
-
1704
Algorithm flowchart of OFEO.
Published 2025“…For the purpose of further enhancing the processing capability of small-scale features, a small target detection head is first introduced to the detection layer of YOLOv8 in this paper with the aim of collecting more detailed information by increasing the detection resolution of YOLOv8 to ensure precise and fast detection. …”
-
1705
Partial tracking results of MOT17 dataset.
Published 2025“…For the purpose of further enhancing the processing capability of small-scale features, a small target detection head is first introduced to the detection layer of YOLOv8 in this paper with the aim of collecting more detailed information by increasing the detection resolution of YOLOv8 to ensure precise and fast detection. …”
-
1706
Improved detection layer.
Published 2025“…For the purpose of further enhancing the processing capability of small-scale features, a small target detection head is first introduced to the detection layer of YOLOv8 in this paper with the aim of collecting more detailed information by increasing the detection resolution of YOLOv8 to ensure precise and fast detection. …”
-
1707
The performance of S-YOFEO model on MOT16.
Published 2025“…For the purpose of further enhancing the processing capability of small-scale features, a small target detection head is first introduced to the detection layer of YOLOv8 in this paper with the aim of collecting more detailed information by increasing the detection resolution of YOLOv8 to ensure precise and fast detection. …”
-
1708
The matching process of EIOU.
Published 2025“…For the purpose of further enhancing the processing capability of small-scale features, a small target detection head is first introduced to the detection layer of YOLOv8 in this paper with the aim of collecting more detailed information by increasing the detection resolution of YOLOv8 to ensure precise and fast detection. …”
-
1709
60 Hz-induced neural entrainment.
Published 2025“…Statistical significance for these inter-group comparisons was assessed using the Wilcoxon rank-sum test. …”
-
1710
Table 1_The effect of self-compassion versus mindfulness interventions on autonomic responses to stress in generalized anxiety disorders.docx
Published 2025“…We also demonstrated a significant correlation between decreased heart rate response and less negative emotions.…”
-
1711
Data Sheet 1_Knowledge, attitude, and practice toward foodborne disease among Chinese college students: a cross-sectional survey.pdf
Published 2024“…In particular, there was a notable decrease in practice scores toward foodborne diseases among male students, ethnic minority students, and non-medical students. …”
-
1712
Bias risk assessment of included studies.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
-
1713
Forest plot for hs-CRP.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
-
1714
Forest plot for IL-6.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
-
1715
The incidence rate of adverse reactions.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
-
1716
The PRISMA study flowchart.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
-
1717
Forest plot for FEV1/FVC.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
-
1718
Forest plot for clinical efficacy.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
-
1719
Forest plot for FEV1.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
-
1720
The excluded and included studies were listed.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”